BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN BEGIN:VEVENT UID:926@biocityturku.fi DTSTART;TZID=Europe/Helsinki:20260520T120000 DTEND;TZID=Europe/Helsinki:20260520T130000 DTSTAMP:20260521T075701Z URL:https://biocityturku.fi/events/inflames-guest-seminar-3/ SUMMARY:InFLAMES Guest Seminar DESCRIPTION:20th May at 12:00-13:00\nHybrid event\nin in Medisiina C\, Osmo Järvi lecture hall\n\nProfessor Antonio Lanzavecchia\, National Institu te of Molecular Genetics (INGM)\, Milano\, Italy\nImmunodominance in CD8 T cell responses\n\nHost: Sirpa Jalkanen (sirjal@utu.fi)\n\nCoffee and sand wiches served at 11:30.\n\nThose outside Turku\, please request the online link from sampo.koivunen@utu.fi by May 19.\n\n \;\n\nProfessor Anto nio Lanzavecchia is known for his work on antigen presentation\, T cell a ctivation\, immunological memory and human monoclonal antibodies. Lanzavec chia obtained a medical degree from the University of Pavia\, where he spe cialized in paediatrics and in infectious diseases. Since 1983 he works in Switzerland\, first as a scientific member of the Basel Institute for Imm unology and since 2000 as the founding director of the Institute for Resea rch in Biomedicine in Bellinzona. Lanzavecchia has been professor of Immun ology at the University of Genova and Siena and at the Swiss Federal Insti tute of technology\, ETH Zürich. He is member of the EMBO\, fellow of the Royal College of Physicians and is honorary member of the American Societ y for Immunology\, of the Swiss Society of Immunology and of the Swiss Aca demy of Medical Sciences. In 2016 he has been elected as international mem ber of the U.S. National Academy of Sciences. He received the EMBO gold Me dal\, the Cloetta prize\, the Robert Koch prize\, the Sanofi-Institut Past eur prize and the Louis-Jeantet Prize for Medicine. Lanzavecchia is the sc ientific Founder of Humabs Biomed\, now a subsidiary of Vir Biotecnology a nd is currently senior Research fellow at Vir Biotecnology. His academic r esearch continues at the INGM.\n\n \;\n\nSelected publications\n\nPhad \, G.E.\, Pinto\, D.\, Foglierini\, M. et al. Clonal structure\, stabili ty and dynamics of human memory B cells and circulating plasmablasts. Nat Immunol 23\, 1076–1085 (2022). https://doi.org/10.1038/s41590-022-01230 -1 \n\nChen\, Y.\, Xu\, K.\, Piccoli\, L. et al. Structural basis of ma laria RIFIN binding by LILRB1-containing antibodies. Nature 592\, 639– 643 (2021). https://doi.org/10.1038/s41586-021-03378-6\n\nCassotta\, A.\,  Paparoditis\, P. et al. Deciphering and predicting CD4+ T cell immuno dominance of influenza virus hemagglutinin. J Exp Med 5 October 2020\; 2 17 (10): e20200206. doi: https://doi.org/10.1084/jem.20200206\n\nJoshua T an\, Luca Piccoli\, Antonio Lanzavecchia. 2019. The Antibody Response to  Plasmodium falciparum: Cues for Vaccine Design and the Discovery of Recept or-Based Antibodies. Annual Review Immunology. 37:225-246. https://doi.o rg/10.1146/annurev-immunol-042617-053301 ATTACH;FMTTYPE=image/jpeg:https://biocityturku.fi/wp-content/uploads/2023/ 10/inflames-thumbnail.jpg CATEGORIES:Other events END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Helsinki X-LIC-LOCATION:Europe/Helsinki BEGIN:DAYLIGHT DTSTART:20260329T040000 TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST END:DAYLIGHT END:VTIMEZONE END:VCALENDAR